Individuals Stopping Weight-Loss Jabs Put On Weight Four Times Faster Compared to Those on Conventional Diets

Illustration of medical injection and weighing machine
Obesity treatment involves long-term strategies.

Fresh analysis suggests that individuals who stop using new weight-loss injections like semaglutide or tirzepatide may regain lost weight much more quickly than those who stop conventional lifestyle programs.

Published data in a leading medical journal points out that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month after stopping.

"Users buying such drugs should be informed of the potential of quick rebound weight gain when the treatment concludes," stated researcher Dr. Susan Jebb.

That rate of recovery suggests a return to original weight in about one and a half years.

Weighing Treatments

The study, which reviewed dozens of trials involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with other pills.

The team point out that individuals who lose weight through dieting usually see a less rapid creep back—around 0.1 kg a month—post-intervention.

Explaining the Quick Regain

Doctors suggest the way of the drugs accounts for the accelerated regain.

GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Artificially providing GLP-1 levels far above than the body's typical production could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication means appetite is uncontrolled, making overeating a significant risk."

An Ongoing Disease?

Medical guidelines suggest the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.

Professionals say that, given the significant potential of weight regain, the treatment should be considered long-term.

This view is supported by drug manufacturers, who state that the results "highlight the long-term character of excess weight," akin to managing diseases like hypertension.

Patient Experiences

Users who have come off the medication explain a powerful resurgence of hunger.

"It felt as if a trigger that goes on and I was suddenly extremely hungry," described an individual.

The struggle is worsened if users have not established lasting dietary or behavioural changes during treatment.

Significant Interest

Recent estimates show that millions of adults in the UK have used these injections in the last 12 months, with desire remaining high.

  • Use is greater among women than males.
  • The 40s and 50s demographic shows the highest usage rates.
  • Many obtain the medications through private prescriptions rather than public health services.

Ultimately, experts emphasize that while the jabs are powerful tools for weight loss, they are not a permanent fix and maintained weight loss hinges on combined behavioural changes.

Jessica Dean
Jessica Dean

A professional poker player and writer, sharing insights from over a decade of experience in tournaments across Europe.